Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
12.08
-0.58 (-4.58%)
At close: May 15, 2026, 4:00 PM EDT
12.11
+0.03 (0.25%)
After-hours: May 15, 2026, 7:37 PM EDT

Immunic Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
186.6315.4835.6746.67106.7586.86
Short-Term Investments
----9.63-
Cash & Short-Term Investments
186.6315.4835.6746.67116.3786.86
Cash Growth
1204.73%-56.59%-23.58%-59.89%33.97%-31.85%
Other Current Assets
2.137.393.665.869.4918.13
Total Current Assets
188.7622.8739.3352.53125.86104.99
Net Property, Plant & Equipment
0.981.181.541.771.851.1
Goodwill
-----32.97
Other Long-Term Assets
----0.040.04
Total Assets
189.7424.0540.8754.3127.75139.1
Accounts Payable
11.0110.147.855.14.283.75
Accrued Expenses
22.4318.6512.9118.667.997.07
Other Current Liabilities
4.921.841.420.970.810.59
Total Current Liabilities
38.3630.6222.1824.7313.0811.4
Long-Term Leases
0.150.110.260.640.990.58
Total Long-Term Liabilities
0.150.110.260.640.990.58
Total Liabilities
38.5130.7322.4425.3714.0711.99
Preferred Stock
--0.01---
Common Stock
0.01-0.01000
Additional Paid-in Capital
789.32599.24525.61436.06427.93324.24
Accumulated Other Comprehensive Income
3.062.654.213.763.04-0.25
Retained Earnings
-641.16-608.57-511.4-410.89-317.28-196.87
Shareholders' Equity
151.23-6.6818.4428.93113.68127.12
Total Liabilities & Equity
189.7424.0540.8754.3127.75139.1
Total Debt
0.150.110.260.640.990.58
Net Cash (Debt)
186.4815.3835.446.04115.3886.28
Net Cash Growth
1112.82%-56.57%-23.09%-60.10%33.73%-31.94%
Net Cash Per Share
9.080.993.5310.3936.2636.48
Book Value
151.23-6.6818.4428.93113.68127.12
Book Value Per Share
7.36-0.431.846.5335.7353.74
Tangible Book Value
151.23-6.6818.4428.93113.6894.15
Tangible Book Value Per Share
7.36-0.431.846.5335.7339.80
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q